Synthesis of naphtho[2,3-a]phenoxazinium chlorides: Structure-activity relationships of these heterocycles and benzo[a]phenoxazinium chlorides as new antimicrobials

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 6, 2008, Pages 3274-3282

  Frade, Vânia H J ^a   Sousa, Maria J ^a   Moura, João C V P ^a   Gonçalves, M Sameiro T ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Antifungal activity; Benzo a phenoxazines; Functionalised probes; Long wavelength fluorescent dyes; Naphtho 2,3 a phenoxazinium salts

Indexed keywords

3 (ANTHRACEN 1 YLAMINO)PROPAN 1 OL; ALKYL GROUP; ANTIFUNGAL AGENT; CHLORINE DERIVATIVE; ETHYL 4 (ANTHRACEN 1 YLAMINO)BUTANOIC ACID; HETEROCYCLIC COMPOUND; N (2 METHYL 7 PROPYLAMINO 3H NAPHTHO[2,3 A]PHENOXAZIN 3 YLIDENE)ETHANAMINIUM CHLORIDE; N (7 AMINO 2 METHYL 3H NAPHTHO[2,3 A]PHENOXAZIN 3 YLIDENE)ETHANAMINIUM CHLORIDE; N 1 (ANTHRACEN 1 YL)PROPANE 1,3 DIAMINE; N [7 (3 AMINOPROPYLAMINO) 2 METHYL 3H NAPHTHO[2,3 A]PHENOXAZIN 3 YLIDENE]ETHANAMINIUM CHLORIDE; N [7 (3 CHLOROPROPYLAMINO) 2 METHYL 3H NAPHTHO[2,3 A]PHENOXAZIN 3 YLIDENE]ETHANAMINIUM CHLORIDE; N [7 (3 HYDROXYPROPYLAMINO) 2 METHYL 3H NAPHTHO[2,3 A]PHENOXAZIN 3 YLIDENE]ETHANAMINIUM CHLORIDE; N [7 (4 ETHOXY 4 OXOBUTYLAMINO) 2 METHYL 3H NAPHTHO[2,3 A]PHENOXAZIN 3 YLIDENE]ETHANAMINIUM CHLORIDE; N PROPYLANTHRACEN 1 AMINE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; BROTH DILUTION; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL BOND; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

AMINO ACIDS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; CROSS-LINKING REAGENTS; MICROBIAL SENSITIVITY TESTS; OXAZINES; SACCHAROMYCES CEREVISIAE; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP;

SACCHAROMYCES CEREVISIAE;

EID: 40949137821     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.12.013     Document Type: Article

References (31)

1. Jose J., and Burgess K. Tetrahedron 62 (2006) 11021-11037
2. Ghoneim N. Spectrochim. Acta A 56 (2000) 1003-1010
3. Rahavendran S.V., and Karnes H.T. J. Pharm. Biomed. Anal. 15 (1996) 83-98
4. Frade V.H.J., Coutinho P.J.G., Moura J.C.V.P., and Gonçalves M.S.T. Tetrahedron 63 (2007) 1654-1663
5. Theodoropulos, S. U.S. Patent 4,873,318, 1989.
6. Salomi B.S.B., Mitra C.K., and Gorton L. Synth. Met. 155 (2005) 426-429
7. Simmonds, A.; Miller, J. N.; Moody, C. J.; Swann, E.; Briggs, M. S. J.; Bruce, I. E. Eur. Patent WO97,29154, 1997.
8. Soto C.Y., Andreu N., Gibert I., and Luquin M. J. Clin. Microbiol. 40 (2002) 3021-3024
9. Yan, X.; Miragila, S.; Yuan, P.M. U.S. Patent 6,140,500, 2000.
10. Lahti R., Salminen T., Latonen S., Heikinheimo P., Pohjanoksa K., and Heinonen J. Eur. J. Biochem. 198 (1991) 293-297
11. Nakanishi J., Nakajima T., Sato M., Ozawa T., Tohda K., and Umezawa Y. Anal. Chem. 73 (2001) 2920-2928
12. Petrassi H.M., Klabunde T., Sacchettini J., and Kelly J.W. J. Am. Chem. Soc. 122 (2000) 2178-2192
13. Küçükkilinç T., and Ozer I. Arch. Biochem. Biophys. 461 (2007) 294-298
14. Abe A., Yamane M., and Tomoda A. Anti-cancer Drugs 12 (2001) 377-382
15. Shimamoto T., Tomoda A., Ishida R., and Ohyashiki K. Clin. Cancer Res. 7 (2001) 704-708
16. Alberti A., Bolognese A., Guerra M., Lavecchia A., Macciantelli D., Marcaccio M., Novellino E., and Paolucci F. Biochemistry 42 (2003) 11924-11931
17. Bolognese A., Correale G., Manfra M., Lavecchia A., Mazzoni O., Novellino E., Barone V., Pani A., Tramontano E., La Colla P., Murgioni C., Serra I., Setzu G., and Loddo R. J. Med. Chem. 45 (2001) 5205-5216
18. Bolognese A., Correale G., Manfra M., Lavecchia A., Mazzoni O., Novellino E., Barone V., La Colla P., and Loddo R. J. Med. Chem. 45 (2002) 5217-5223
19. Shimizu S., Suzuki M., Tomoda A., Arai S., Taguchi H., Hanawa T., and Kamiya S. Tohoku J. Exp. Med. 203 (2004) 47-52
20. Foley J.W., Song X., Demidova T.N., Jilal F., and Hamblin M.R. J. Med. Chem. 49 (2006) 5291-5299
21. Bolognese A., Correale G., Manfra M., Lavecchia A., Novellino E., and Pepe S. J. Med. Chem. 49 (2006) 5110-5118
22. Shirato K., Imaizumi K., Abe A., and Tomoda A. Biol. Pharm. Bull. 30 (2007) 331-336
23. Piloto A.M., Rovira D., Costa S.P.G., and Gonçalves M.S.T. Tetrahedron 62 (2006) 11955-11962
24. Frade V.H.J., Gonçalves M.S.T., Coutinho P.J.G., and Moura J.C.V.P. J. Photochem. Photobiol. 185 (2007) 220-230
25. Crossley M.L., Turner R.J., Hofmann C.M., Dreisbach P.F., and Parker R.P. J. Am. Chem. Soc. 74 (1952) 578-584
26. Frade V.H.J., Sousa M.J., Moura J.C.V.P., and Gonçalves M.S.T. Tetrahedron Lett. 48 (2007) 8347-8352
27. Sens R., and Drexhage K.H. J. Luminescence 24 (1981) 709-712
28. Frade V.H.J., Barros S.A., Moura J.C.V.P., and Gonçalves M.S.T. Tetrahedron Lett. 48 (2007) 3403-3407
29. Cincotta, L.; Foley, J. W. U.S. Patent 4,962,197, 1990.
30. Vázquez J.L., Merino S., Domenech O., Berlanga M., Viñas M., Montero M.T., and Hernández-Borrell J. Int. J. Pharm. 220 (2001) 53-62
31. Calculation of molecular properties and drug-likeness-Molinspiration cheminformatics software tools (http://www.molinspiration.com).